Compounds > sb 216763
Page last updated: 2024-09-05

sb 216763 and su 9516

sb 216763 has been researched along with su 9516 in 2 studies

Compound Research Comparison

Studies
(sb 216763)		Trials
(sb 216763)		Recent Studies (post-2010)
(sb 216763)		Studies
(su 9516)		Trials
(su 9516)		Recent Studies (post-2010) (su 9516)
342022542019

Protein Interaction Comparison

ProteinTaxonomysb 216763 (IC50)su 9516 (IC50)
Chain A, Cell division protein kinase 2Homo sapiens (human)0.13
Chain A, Cell division protein kinase 2Homo sapiens (human)0.13
Chain A, Cell division protein kinase 2Homo sapiens (human)0.13
Chain A, Cell division protein kinase 2Homo sapiens (human)0.13
photoreceptor-specific nuclear receptorHomo sapiens (human)1.194
Cyclin-T1Homo sapiens (human)1.5
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.022
Cyclin-dependent kinase 1Homo sapiens (human)0.0712
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)1.6
Platelet-derived growth factor receptor betaHomo sapiens (human)0.12
Cyclin-dependent kinase 4Homo sapiens (human)0.7333
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.12
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.095
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)5
Cyclin-A2Homo sapiens (human)0.027
G1/S-specific cyclin-D1Homo sapiens (human)1.7
G1/S-specific cyclin-E1Homo sapiens (human)0.0887
Cyclin-dependent kinase 2Homo sapiens (human)0.0657
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.1233
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.35
Glycogen synthase kinase-3 betaHomo sapiens (human)0.35
Cyclin-dependent kinase 7Homo sapiens (human)0.905
Cyclin-dependent kinase 9Homo sapiens (human)1.5
Cyclin-HHomo sapiens (human)0.905
CDK-activating kinase assembly factor MAT1Homo sapiens (human)0.905
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.0435
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.022
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.022

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flajolet, M; Greengard, P; Meijer, L1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1

Reviews

1 review(s) available for sb 216763 and su 9516

ArticleYear
Pharmacological inhibitors of glycogen synthase kinase 3.
    Trends in pharmacological sciences, 2004, Volume: 25, Issue:9

    Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship

2004

Other Studies

1 other study(ies) available for sb 216763 and su 9516

ArticleYear
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
chemdatabank.com